Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Halozyme Therapeutics
Investors Business Daily
Saturday, February 11, 2012 - 11:42am
tags:
Halozyme
Celgene Takes Smart Risks, Invests For The Long Run
Investors.com
Saturday, February 11, 2012 - 11:41am
tags:
Celgene
Osiris Provides Update on Sanofi Deal
Yahoo/Zacks
Saturday, February 11, 2012 - 11:40am
tags:
Osiris Therapeutics, Sanofi, Prochymal, graft vs host disease
FDA proposed guidelines open the door to biosimilars
Reuters
Saturday, February 11, 2012 - 11:38am
tags:
FDA, biosimilars
Alnylam to Webcast Presentations at Upcoming Investor Conferences
Yahoo/BusinessWire
Saturday, February 11, 2012 - 11:37am
tags:
Alnylam
Biotech: A “Stock Picker’s Delight,” Says Morgan Stanley
Barron's
Saturday, February 11, 2012 - 11:36am
tags:
Biogen Idec, Cellgene, Gilead Sciences
Amyris shares tumble on outlook
Yahoo/AP
Saturday, February 11, 2012 - 11:35am
tags:
Amyris
LEO Pharma slapped with sales-rep overtime suit
Fierce Pharma
Friday, February 10, 2012 - 11:14am
tags:
overtime lawsuits, drug reps, LEO Pharma
[video] The Next Big Thing in Biotech: BIO CEO Conference
TheStreet.com
Friday, February 10, 2012 - 10:57am
tags:
BIO CEO Conference, biotech
WellPoint to Cease Branded Lipitor Coverage, Favor Generics
WSJ Online
Friday, February 10, 2012 - 10:56am
tags:
Lipitor, generics, statins, Pfizer, Wellpoint
Eisai gets bad news for Dacogen but excitement over Alzheimer study
Pharma Times, UK
Friday, February 10, 2012 - 10:55am
tags:
Dacogen, Alzheimer's disease, Eisai, Astex, Targretin
Which Pharma Spent The Most R&D On Each Drug?
Pharmalot
Friday, February 10, 2012 - 10:54am
tags:
R&D, Amgen, AstraZeneca, Abbott Laboratories, Eli Lilly
Can Vertex Pharma shares stage a comeback?
Marketwatch
Friday, February 10, 2012 - 10:51am
tags:
Vertex Pharmaceuticals, Incivek, hepatitis C
BioSante: LibiGel Lives On, FDA Word On Bio-T-Gel May Come At Any Time
Seeking Alpha
Friday, February 10, 2012 - 10:50am
tags:
LibiGel, FDA, BioSante, Bio-T-Gel, female sexual dysfunction, Teva Pharmaceuticals, hypogonadism
India's global pharmacy role threatened by EU pact
Yahoo/AP
Friday, February 10, 2012 - 10:49am
tags:
India, Europe
$10 Billion Market Opportunity For Oculus
Seeking Alpha
Friday, February 10, 2012 - 10:47am
tags:
Oculus Innovative Sciences, Microcyn, antibiotics, antibiotic resistance
Pharmacyclics rises after posting 2Q profit
Yahoo/AP
Friday, February 10, 2012 - 10:46am
tags:
earnings, Pharmacyclics
FDA releases long-awaited plan to review first generic versions of pricey biotech drugs
Yahoo/AP
Friday, February 10, 2012 - 10:45am
tags:
FDA, generics, biotech
Positive Results on Forest/Gedeon Drug Positive Results on Forest/Gedeon Drug Positive Results on Forest/Gedeon Drug
Yahoo/Zacks
Friday, February 10, 2012 - 10:44am
tags:
Forest Labs, Gedeon, cariprazine, antipsychotics
Glaxo Tests Cheaper Version of Advair for Emerging Markets
Bloomberg
Thursday, February 9, 2012 - 12:07pm
tags:
GSK, Advair, Seretide, asthma, emerging markets

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.